MEDISAFE TECHNOLOGIES - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
88593452
Word Mark
MEDISAFE TECHNOLOGIES
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2020-06-21
Filing Date
2019-08-26
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
241504, 260101, 260102, 261102, 261712 - Arrowheads. Circles as carriers or as single line borders. Plain single line circles. Plain single line rectangles. Chevrons and angles.
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
DIBLE, JONATHON I
Statements
Indication of Colors claimed
The color(s) red and blue is/are claimed as a feature of the mark.
Description of Mark
The mark consists of The words MEDISAFE TECHNOLOGIES in blue surrounded by a blue box with a circle surrounding a red and blue arrow.
Goods and Services
Medical examination gloves
Pseudo Mark
MEDICAL SAFE TECHNOLOGIES
Classification Information
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2019-09-09
Primary Code
010
Correspondences
Name
PERRY CLARK
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2019-08-29 | NEW APPLICATION ENTERED IN TRAM |
2019-09-09 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-09-10 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2019-11-25 | ASSIGNED TO EXAMINER |
2019-11-27 | NON-FINAL ACTION WRITTEN |
2019-11-27 | NON-FINAL ACTION E-MAILED |
2019-11-27 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-06-21 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2020-06-22 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |